BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo W, Lu X, Liu Q, Zhang T, Li P, Qiao W, Deng M. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Med 2019;8:4135-48. [PMID: 31197958 DOI: 10.1002/cam4.2281] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Youssry S, Hussein A, Ramadan R, Alkarmouty A, Elsheredy A. The association of human cytomegalovirus with biomarkers of inflammation and immune activation in breast cancer. BD 2022;41:229-39. [DOI: 10.3233/bd-210060] [Reference Citation Analysis]
2 Fujii T, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, Shirabe K. Implications of Low Serum Albumin as a Prognostic Factor of Long-term Outcomes in Patients With Breast Cancer. In Vivo 2020;34:2033-6. [PMID: 32606178 DOI: 10.21873/invivo.12003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Han SN, Feng SJ, Liu Y. Prognostic and clinicopathological significance of the platelet-to-lymphocyte ratio in melanoma: A meta-analysis involving 2099 patients. Kaohsiung J Med Sci 2021;37:55-62. [PMID: 32783332 DOI: 10.1002/kjm2.12290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Shi H, Wang XH, Gu JW, Guo GL. Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients. Cancer Manag Res 2019;11:10827-39. [PMID: 31920392 DOI: 10.2147/CMAR.S234926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med 2020;18:360. [PMID: 33213430 DOI: 10.1186/s12916-020-01817-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
6 Kim R, Kawai A, Wakisaka M, Sawada S, Shimoyama M, Yasuda N, Hidaka M, Morita Y, Ohtani S, Ito M, Kawasaki K, Kin T, Arihiro K. Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer. Transl Oncol 2021;14:100927. [PMID: 33157515 DOI: 10.1016/j.tranon.2020.100927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ntalouka MP, Nana P, Kouvelos GN, Stamoulis K, Spanos K, Giannoukas A, Matsagkas M, Arnaoutoglou E. Association of Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio with Adverse Events in Endovascular Repair for Abdominal Aortic Aneurysm. J Clin Med 2021;10:1083. [PMID: 33807721 DOI: 10.3390/jcm10051083] [Reference Citation Analysis]
8 Al Jarroudi O, El Bairi K, Abda N, Zaimi A, Jaouani L, Chibani H, Afqir S. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Biomark Med 2021;15:1289-98. [PMID: 34486882 DOI: 10.2217/bmm-2020-0717] [Reference Citation Analysis]
9 Hu Y, Wang S, Ding N, Li N, Huang J, Xiao Z. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2-) Breast Cancer. Clin Breast Cancer 2020;20:e403-9. [PMID: 32201163 DOI: 10.1016/j.clbc.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Cong R, Kong F, Ma J, Li Q, Wu Q, Ma X. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. BMC Cancer 2020;20:464. [PMID: 32448185 DOI: 10.1186/s12885-020-06953-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Quaresmini D, Di Lauro A, Fucci L, Strippoli S, De Risi I, Sciacovelli AM, Albano A, Achille G, Montepara M, Russo S, Tassone G, Guida M. Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp. Front Oncol 2021;11:742666. [PMID: 34604086 DOI: 10.3389/fonc.2021.742666] [Reference Citation Analysis]
12 Lee PY, Oen KQX, Lim GRS, Hartono JL, Muthiah M, Huang DQ, Teo FSW, Li AY, Mak A, Chandran NS, Tan CL, Yang P, Tai ES, Ng KWP, Vijayan J, Chan YC, Tan LL, Lee MB, Chua HR, Hong WZ, Yap ES, Lim DK, Yuen YS, Chan YH, Aminkeng F, Wong ASC, Huang Y, Tay SH. Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers (Basel) 2021;13:1308. [PMID: 33804050 DOI: 10.3390/cancers13061308] [Reference Citation Analysis]
13 Bae SJ, Cha YJ, Yoon C, Kim D, Lee J, Park S, Cha C, Kim JY, Ahn SG, Park HS, Park S, Kim SI, Jeong J. Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy. Sci Rep 2020;10:13078. [PMID: 32753659 DOI: 10.1038/s41598-020-69965-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mao S, Yu X, Sun J, Yang Y, Shan Y, Sun J, Mugaanyi J, Fan R, Wu S, Lu C. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection. BMC Cancer 2022;22:249. [PMID: 35255845 DOI: 10.1186/s12885-022-09345-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel) 2021;13:4287. [PMID: 34503097 DOI: 10.3390/cancers13174287] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jiang L, Fang J, Ding J. High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab. Cancer Manag Res 2020;12:475-84. [PMID: 32021460 DOI: 10.2147/CMAR.S231444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Guan Y, Xiong H, Feng Y, Liao G, Tong T, Pang J. Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis. Prostate Cancer Prostatic Dis 2020;23:220-31. [PMID: 32034294 DOI: 10.1038/s41391-020-0209-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
18 Jiang C, Lu Y, Zhang S, Huang Y. Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Biomed Res Int 2020;2020:7961568. [PMID: 33381583 DOI: 10.1155/2020/7961568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhou JY, Lu KK, Fu WD, Shi H, Gu JW, Lu YQ, Guo GL. Development of prognostic nomograms using institutional data for patients with triple-negative breast cancer. Future Oncol 2021;17:5077-91. [PMID: 34704816 DOI: 10.2217/fon-2021-0677] [Reference Citation Analysis]
20 Li A, Mu X, He K, Wang P, Wang D, Liu C, Yu J. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases. Future Oncol 2020;16:2433-44. [PMID: 32664750 DOI: 10.2217/fon-2020-0423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ. Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial. Clin Cancer Res 2020;26:4863-8. [PMID: 32546645 DOI: 10.1158/1078-0432.CCR-20-0704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Orlandini LF, Pimentel FF, Andrade JM, Reis FJCD, Mattos-Arruda L, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Braz J Med Biol Res 2021;54:e11409. [PMID: 34406210 DOI: 10.1590/1414-431X2021e11409] [Reference Citation Analysis]
23 Chen L, Kong X, Wang Z, Wang X, Fang Y, Wang J. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator. Cancer Manag Res 2020;12:1543-67. [PMID: 32184659 DOI: 10.2147/CMAR.S235519] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
24 Shao Y, Li W, Wang D, Wu B. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis. World J Surg Oncol 2020;18:273. [PMID: 33097052 DOI: 10.1186/s12957-020-02048-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Qian C, Cai R, Zhang W, Wang J, Hu X, Zhang Y, Jiang B, Yuan H, Liu F. Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients. Front Oncol 2021;11:710704. [PMID: 34307180 DOI: 10.3389/fonc.2021.710704] [Reference Citation Analysis]
26 Li JL, Hsieh TL, Ou MC, Lin FC, Tsai SC. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients. Oral Oncol 2022;126:105729. [PMID: 35144206 DOI: 10.1016/j.oraloncology.2022.105729] [Reference Citation Analysis]
27 Yan X, Li G. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer. Biosci Rep 2020;40:BSR20200352. [PMID: 32175568 DOI: 10.1042/BSR20200352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Lusho S, Durando X, Mouret-Reynier MA, Kossai M, Lacrampe N, Molnar I, Penault-Llorca F, Radosevic-Robin N, Abrial C. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients. Front Oncol 2021;11:678315. [PMID: 34367964 DOI: 10.3389/fonc.2021.678315] [Reference Citation Analysis]
29 Petrucci GN, Lobo L, Queiroga F, Martins J, Prada J, Pires I, Henriques J. Neutrophil-to-lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas. Vet Comp Oncol 2021;19:482-91. [PMID: 33576562 DOI: 10.1111/vco.12686] [Reference Citation Analysis]
30 Morkavuk ŞB, Kocaöz S, Korukluoğlu B. Diagnostic value of Platelet/lymphocyte Ratio (PLR) for predicting sentinel axillary lymph node positivity in early-stage breast cancer compared with ultrasonography. Int J Clin Pract 2021;:e14939. [PMID: 34605138 DOI: 10.1111/ijcp.14939] [Reference Citation Analysis]
31 Van Berckelaer C, Van Geyt M, Linders S, Rypens C, Trinh XB, Tjalma WAA, Van Laere S, Colpaert C, Dirix L, van Dam PA. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer. Breast 2020;53:212-20. [PMID: 32890963 DOI: 10.1016/j.breast.2020.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Liu XB, Gao ZY, Zhang QH, Pandey S, Gao B, Yang F, Tong Q, Li SB. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis. Front Oncol 2020;10:178. [PMID: 32154173 DOI: 10.3389/fonc.2020.00178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Gilmore N, Mohile S, Lei L, Culakova E, Mohamed M, Magnuson A, Loh KP, Maggiore R, Belcher E, Conlin A, Weiselberg L, Ontko M, Janelsins M. The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy. Breast Cancer Res 2021;23:19. [PMID: 33546731 DOI: 10.1186/s13058-021-01388-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Guida M, Bartolomeo N, Quaresmini D, Quaglino P, Madonna G, Pigozzo J, Di Giacomo AM, Minisini AM, Tucci M, Spagnolo F, Occelli M, Ridolfi L, Queirolo P, De Risi I, Valente M, Sciacovelli AM, Chiarion Sileni V, Ascierto PA, Stigliano L, Strippoli S. Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. J Transl Med 2022;20:159. [PMID: 35382857 DOI: 10.1186/s12967-022-03359-x] [Reference Citation Analysis]
35 Guo W, Lu X, Liu Q, Zhang T, Li P, Qiao W, Deng M. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Med 2019;8:4135-48. [PMID: 31197958 DOI: 10.1002/cam4.2281] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
36 Wang Y, Lu S, Shao Y, Peng R, Li X, Wang J, Wang H. Deep regional hyperthermia combined with modern concurrent chemoradiotherapy increases T-downstaging rate in locally advanced rectal cancer. Int J Hyperthermia 2022;39:431-6. [PMID: 35236210 DOI: 10.1080/02656736.2022.2044077] [Reference Citation Analysis]
37 Cho A, Untersteiner H, Fitschek F, Khalaveh F, Pruckner P, Pavo N, Rössler K, Dorfer C, Gatterbauer B, Höller C, Schmidinger M, Frischer JM. The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor. J Neurooncol 2021;153:497-505. [PMID: 34148164 DOI: 10.1007/s11060-021-03788-6] [Reference Citation Analysis]
38 Kuranari Y, Tamura R, Tsuda N, Kosugi K, Morimoto Y, Yoshida K, Toda M. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas. Front Oncol 2020;10:592470. [PMID: 33330078 DOI: 10.3389/fonc.2020.592470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Chen F, Chen D, Jin L, Xu C, Zhao W, Hu W. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity. Front Oncol 2022;12:845935. [DOI: 10.3389/fonc.2022.845935] [Reference Citation Analysis]
40 De Logu F, Galli F, Nassini R, Ugolini F, Simi S, Cossa M, Miracco C, Gianatti A, De Giorgi V, Rulli E, Cossu A, Massi D, Mandalà M. Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients. Cells 2021;10:422. [PMID: 33671367 DOI: 10.3390/cells10020422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Cacho-Díaz B, Cortes-Ortega MD, Reynoso-Noverón N, Wegman-Ostrosky T, Arriaga-Canon C, Bargalló-Rocha JE. Association of the neutrophil-to-lymphocyte ratio with brain metastases in Hispanic breast cancer patients. Cancer Treat Res Commun 2021;29:100452. [PMID: 34517195 DOI: 10.1016/j.ctarc.2021.100452] [Reference Citation Analysis]
42 Li YX, Chang JY, He MY, Wang HR, Luo DQ, Li FH, Li JH, Ran L. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer. J Oncol 2021;2021:2939162. [PMID: 34539781 DOI: 10.1155/2021/2939162] [Reference Citation Analysis]
43 Alshamsan B, Alshibany A, Elshenawy MA, Badran A, Elhassan T, Ajarim D, Alsayed A, Suleman K, Al-Tweigeri T. Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer. Cancer Manag Res 2021;13:9411-20. [PMID: 35002318 DOI: 10.2147/CMAR.S343549] [Reference Citation Analysis]
44 Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Oncol 2020;18:197. [PMID: 32767977 DOI: 10.1186/s12957-020-01974-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
45 Sun S, Qu Y, Wen F, Yu H. Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer. Biomark Med 2020;14:1341-52. [PMID: 32808809 DOI: 10.2217/bmm-2019-0583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Fujii T, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, Shirabe K. Relationship Between FDG Uptake and the Platelet/lymphocyte Ratio in Patients With Breast Invasive Ductal Cancer. In Vivo 2020;34:1365-9. [PMID: 32354932 DOI: 10.21873/invivo.11915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Pérez-García JM, Llombart-Cussac A, G Cortés M, Curigliano G, López-Miranda E, Alonso JL, Bermejo B, Calvo L, Carañana V, de la Cruz Sánchez S, M Vázquez R, Prat A, R Borrego M, Sampayo-Cordero M, Seguí-Palmer MÁ, Soberino J, Malfettone A, Schmid P, Cortés J. Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial. Eur J Cancer 2021;148:382-94. [PMID: 33794440 DOI: 10.1016/j.ejca.2021.02.028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Ke ZR, Chen W, Li MX, Wu S, Jin LT, Wang TJ. Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients. World J Clin Cases 2022; 10(11): 3389-3400 [DOI: 10.12998/wjcc.v10.i11.3389] [Reference Citation Analysis]
49 Zhang W, Shen Y, Huang H, Pan S, Jiang J, Chen W, Zhang T, Zhang C, Ni C. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment. Front Immunol 2020;11:1779. [PMID: 32849640 DOI: 10.3389/fimmu.2020.01779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Grassadonia A, Graziano V, Iezzi L, Vici P, Barba M, Pizzuti L, Cicero G, Krasniqi E, Mazzotta M, Marinelli D, Amodio A, Natoli C, Tinari N. Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting. Cells 2021;10:1685. [PMID: 34359855 DOI: 10.3390/cells10071685] [Reference Citation Analysis]
51 de la Cruz-Ku G, Chambergo-Michilot D, Torres-Roman JS, Rebaza P, Pinto J, Araujo J, Morante Z, Enriquez D, Flores C, Luque R, Saavedra A, Lujan M, Gomez H, Valcarcel B. Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer. PLoS One 2020;15:e0243447. [PMID: 33284847 DOI: 10.1371/journal.pone.0243447] [Reference Citation Analysis]
52 Miklikova S, Minarik G, Sedlackova T, Plava J, Cihova M, Jurisova S, Kalavska K, Karaba M, Benca J, Smolkova B, Mego M. Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer. Cancers (Basel) 2020;12:E1134. [PMID: 32369910 DOI: 10.3390/cancers12051134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
53 Cui H, Li Y, Li S, Liu G. Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis. Cancer Med 2022. [PMID: 35692190 DOI: 10.1002/cam4.4935] [Reference Citation Analysis]
54 Zhu J, Jiao D, Zhao Y, Guo X, Yang Y, Xiao H, Liu Z. Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients. Sci Rep 2021;11:1350. [PMID: 33446717 DOI: 10.1038/s41598-020-80037-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Ren X, Ling L, Qi L, Liu Z, Zhang W, Yang Z, Wang W, Tu C, Li Z. Patients' risk factors for periprosthetic joint infection in primary total hip arthroplasty: a meta-analysis of 40 studies. BMC Musculoskelet Disord 2021;22:776. [PMID: 34511099 DOI: 10.1186/s12891-021-04647-1] [Reference Citation Analysis]
56 Dal F, Ökmen H, Ulusan K, Havare SB, Orhan B, Çolak Ş, Ferlengez E, Sari S. Hemogram index parameters in the evaluation of male breast cancer and inflammatory response: a case-control study. Rev Assoc Med Bras (1992) 2021:S0104-42302021005012207. [PMID: 34909971 DOI: 10.1590/1806-9282.20210865] [Reference Citation Analysis]